451 related articles for article (PubMed ID: 18095846)
1. Characterization of nanoparticles for therapeutics.
Hall JB; Dobrovolskaia MA; Patri AK; McNeil SE
Nanomedicine (Lond); 2007 Dec; 2(6):789-803. PubMed ID: 18095846
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle therapeutics: a personal perspective.
McNeil SE
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):264-71. PubMed ID: 20049796
[TBL] [Abstract][Full Text] [Related]
3. Evaluating Nanomedicines: Obstacles and Advancements.
Swierczewska M; Crist RM; McNeil SE
Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
[TBL] [Abstract][Full Text] [Related]
4. Radical nanomedicine.
Rzigalinski BA; Meehan K; Davis RM; Xu Y; Miles WC; Cohen CA
Nanomedicine (Lond); 2006 Dec; 1(4):399-412. PubMed ID: 17716143
[TBL] [Abstract][Full Text] [Related]
5. Unique benefits of nanotechnology to drug delivery and diagnostics.
McNeil SE
Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
[TBL] [Abstract][Full Text] [Related]
6. Integration column: biofunctional polymeric nanoparticles for spatio-temporal control of drug delivery and biomedical applications.
Rothenfluh DA; Hubbell JA
Integr Biol (Camb); 2009 Jul; 1(7):446-51. PubMed ID: 20023754
[TBL] [Abstract][Full Text] [Related]
7. Functionalized gold nanoparticles for drug delivery.
Han G; Ghosh P; Rotello VM
Nanomedicine (Lond); 2007 Feb; 2(1):113-23. PubMed ID: 17716197
[TBL] [Abstract][Full Text] [Related]
8. Theranostic nanoparticles engineered for clinic and pharmaceutics.
Ma X; Zhao Y; Liang XJ
Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
[TBL] [Abstract][Full Text] [Related]
9. Are existing standard methods suitable for the evaluation of nanomedicines: some case studies.
Gioria S; Caputo F; Urbán P; Maguire CM; Bremer-Hoffmann S; Prina-Mello A; Calzolai L; Mehn D
Nanomedicine (Lond); 2018 Mar; 13(5):539-554. PubMed ID: 29381129
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, Metabolism, Distribution and Permeability of Nanomedicine.
Ravindran S; Suthar JK; Rokade R; Deshpande P; Singh P; Pratinidhi A; Khambadkhar R; Utekar S
Curr Drug Metab; 2018; 19(4):327-334. PubMed ID: 29512450
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
Gaumet M; Vargas A; Gurny R; Delie F
Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine: sizing up targets with nanoparticles.
Minchin R
Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
[No Abstract] [Full Text] [Related]
13. Nanomedicine: de novo design of nanodrugs.
Yang Z; Kang SG; Zhou R
Nanoscale; 2014 Jan; 6(2):663-77. PubMed ID: 24305636
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases.
Szelenyi I
Inflamm Res; 2012 Jan; 61(1):1-9. PubMed ID: 22057873
[TBL] [Abstract][Full Text] [Related]
15. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.
Uner M; Yener G
Int J Nanomedicine; 2007; 2(3):289-300. PubMed ID: 18019829
[TBL] [Abstract][Full Text] [Related]
16. Micro- and nanoparticles--medical applications.
Jătariu A; Peptu C; Popa M; Indrei A
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.
Soares AF; Carvalho Rde A; Veiga F
Nanomedicine (Lond); 2007 Apr; 2(2):183-202. PubMed ID: 17716120
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine: novel approaches in human and veterinary therapeutics.
Irache JM; Esparza I; Gamazo C; Agüeros M; Espuelas S
Vet Parasitol; 2011 Aug; 180(1-2):47-71. PubMed ID: 21680101
[TBL] [Abstract][Full Text] [Related]
19. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.
Al-Jamal WT; Kostarelos K
Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicines for chronic non-infectious arthritis: the clinician's perspective.
Rubinstein I; Weinberg GL
Maturitas; 2012 Sep; 73(1):68-73. PubMed ID: 22264497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
